Health News Archive - February 03, 2009
Children and teens with healthier nutrition, active lifestyles, food security and greater healthcare access are more likely to use vitamins, researchers say. Dr.
Topical Delivery of ESBA105, an Anti-TNF Alpha Antibody Fragment in Patients Undergoing Cataract Surgery ZURICH, Switzerland, Feb.
FREISING-WEIHENSTEPHAN, Germany, February 3 /PRNewswire/ -- Pieris AG, a biopharmaceutical company developing Anticalins(R), a novel class of targeted human protein therapeutics, reports today that it has made significant progress in the development of its Anticalin(R) candidate PRS-050, a potent VEGF antagonist with broad therapeutic applicability. Having successfully demonstrated the mode of action of PRS-050 in vitro and in vivo, Pieris has now validated the efficacy of the Anticalin(R) product candidate in several preclinical models.
OSLO, Norway, February 3 /PRNewswire-FirstCall/ -- - ALSYMPCA Study Designed to Evaluate Alpharadin for the Treatment of Bone Metastases in Prostate Cancer Patients Algeta ASA (OSE: ALGETA), the cancer therapeutics company, announces that it is to enroll US patients into its ALSYMPCA phase III trial evaluating Alpharadin as a new treatment for bone metastases in patients with hormone-refractory prostate cancer (HRPC).
LEXINGTON, Ky., Feb. 3 /PRNewswire/ -- Just because the economy isn't what it used to be, doesn't mean you have to forgo a Valentine's surprise for that special someone.
DENVER, Feb. 3 /PRNewswire-FirstCall/ -- The Ensign Group, Inc. (Nasdaq: ENSG), announced today that it has expanded into Colorado by acquiring four long-term care facilities in the Denver metropolitan area.
Dr. Vince Mosesso, the medical director of the Sudden Cardiac Arrest Association, offers heart healthy Valentine's Day gift ideas WASHINGTON, Feb.
SOUTH SAN FRANCISCO, Calif., Feb. 3 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will delay further partnership discussions regarding R788 until after results from the Phase 2b clinical trials of R788 are available.
"Be A.L.E.R.T." Initiative Complements New Tube-Feeding Best-Practice Recommendations NEW ORLEANS, Feb.
Leading Health and Nutrition Doctor Joins Top Women's Expert Site SAN FRANCISCO, Feb. 3 /PRNewswire/ -- SmartNow.com, the company dedicated to providing women over 30 with expert health and beauty information along with community, announced today that Dr.
- totally perplexed and mixed up.